0000896262-22-000012.txt : 20220222
0000896262-22-000012.hdr.sgml : 20220222
20220222210204
ACCESSION NUMBER: 0000896262-22-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220217
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gerard Christopher
CENTRAL INDEX KEY: 0001694097
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 22660395
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY, SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_164558170445940.xml
FORM 4
X0306
4
2022-02-17
0
0000896262
AMEDISYS INC
AMED
0001694097
Gerard Christopher
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
President & COO
Common Stock
2022-02-17
4
A
0
6109
0
A
43965
D
Common Stock
2022-02-20
4
F
0
2067
141.07
D
41898
D
Common Stock
279
I
Through 401(k) Plan
Stock Option (Right to Buy)
143.25
2022-02-17
4
A
0
14277
0
A
2032-02-17
Common Stock
14277.0
14277
D
Restricted Stock Unit (Performance-Based Vesting)
2022-02-17
4
A
0
12217
0
A
Common Stock
12217.0
12217
D
The Issuer awarded the Reporting Person 6,109 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs.
The information in this report is based on a plan statement dated as of December 31, 2021.
The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options.
The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2022, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2024, 2025 and 2026, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2022-02-22